Back to News
Market Impact: 0.1
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The First Trust NYSE Arca Biotechnology Index Fund delivered significantly higher 1-year total returns, but also experienced greater volatility and a deeper maximum drawdown. The article provides no specific return, volatility, or drawdown figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- A shock in Brazil sends stocks plunging, while neoclouds take another hit
- Lula wins Brazil runoff after prediction markets favored Bolsonaro
- Brazil’s real sinks after Lula’s re-election victory
- One-Day Wipeout Tops 60% For the Hardest-Hit Brazilian Stocks
- Trump says Brazil election looked ’rigged’, defeated Bolsonaro’s party recognizes Lula win
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)
- How to Extract KPIs From Earnings Transcripts With AI